Inovio Pharmaceuticals (INO) Minority Interest (2010 - 2020)
Inovio Pharmaceuticals (INO) posted Minority Interest of $96269.0 for Q3 2020, little changed sequentially from $96269.0 in Q2 2020, and down 96.03% YoY from $2.4 million in Q4 2019.
Inovio Pharmaceuticals (INO) Minority Interest (2010 - 2020) Analysis & Trends
Inovio Pharmaceuticals has reported Minority Interest for 11 years, with the latest figure at $96269.0 in Q3 2020.
- Quarterly Minority Interest fell 96.03% year-over-year to $96269.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $96269.0 (down 96.03% YoY) and the FY2019 annual result came in at $2.0 million, up 1946.1% from the prior year.
- Minority Interest held at $96269.0 in Q3 2020 per INO's latest filing, from $96269.0 in the prior quarter.
- Over five years, Minority Interest peaked at $3.5 million in Q1 2020 and troughed at $96269.0 in Q2 2016.
- A 5-year average of $807336.1 and a median of $96269.0 in 2016 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2019 and 2020: Minority Interest surged 3075.24% in 2019, then plunged 96.64% in 2020.
- Over 5 years, Minority Interest stood at $96269.0 in 2016, then changed by 0.0% to $96269.0 in 2017, then changed by 0.0% to $96269.0 in 2018, then surged by 1946.1% to $2.0 million in 2019, then tumbled by 95.11% to $96269.0 in 2020.
- According to Business Quant data, Minority Interest over the past three periods registered $96269.0, $96269.0, and $3.5 million for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 96,269.00 |
| Jun 30, 2020 | 96,269.00 |
| Mar 31, 2020 | 3.53 Mn |
| Dec 31, 2019 | 1.97 Mn |
| Sep 30, 2019 | 2.43 Mn |
| Jun 30, 2019 | 2.86 Mn |
| Mar 31, 2019 | 3.06 Mn |
| Dec 31, 2018 | 96,269.00 |
| Sep 30, 2018 | 96,269.00 |
| Jun 30, 2018 | 96,269.00 |
| Mar 31, 2018 | 96,269.00 |
| Dec 31, 2017 | 96,269.00 |
| Sep 30, 2017 | 96,269.00 |
| Jun 30, 2017 | 96,269.00 |
| Mar 31, 2017 | 96,269.00 |
| Dec 31, 2016 | 96,269.00 |
| Sep 30, 2016 | 96,269.00 |
| Jun 30, 2016 | 96,269.00 |
| Mar 31, 2016 | 245,828.00 |
| Dec 31, 2015 | 245,828.00 |